I very rarely invest in biotech stocks anymore after having the summer of a lifetime in 2012. It was during that summer that I successfully traded the run-up and/or post approval pops of Arena Pharmaceuticals, Rosetta Genomics, Vivus Inc., Amarin Corp, and Orexigen Therapeutics, Inc. It was that summer of obesity, fish oils, and RNA that taught me just how fickle the biotech markets could be and just how quickly a newcomer could lose his shirt buying at the wrong time. I mean somebody was buying when I was hitting sell at the post approval highs and for the most part all these years later that somebody still hasn't recovered. Since then I've avoided anything to do with biotech outside...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|